The New Jersey Attorney General Has Adopted Proposed Amendments to Gift Ban Regulation, With Changes

May 08, 2019


Applicable Manufacturers Must Submit Their Reports of Payments or Other Transfers of Value to APRNs Engaged in Independent Practice in Connecticut by July 1, 2019

May 06, 2019


The District of Columbia Department of Health has Posted on Its Website the 2018 Prescription Drug Marketing Cost Reporting Form

May 01, 2019


California Requires Pharmaceutical and Medical Device Companies to Annually Declare Compliance with Their Comprehensive Compliance Program

April 23, 2019


Data Capture for Expanded List of Federal Covered Recipients Will Begin in Calendar Year 2021 for reporting in 2022

April 18, 2019


U.S. House of Representatives Has Introduced Legislation Amending Sunshine Act to Require Reporting of Medical Supply Samples

April 17, 2019


CMS Open Payments Annual Report to Congress for Program Year 2017 Shows Slight Decrease in Total Dollar Value of Reported Payments

April 10, 2019


Maine Board of Pharmacy Proposes Regulations to Define Modest Meals, Reasonable Honoraria for Implementing Prohibition on Gifts to Practitioners

April 09, 2019


Manufacturers and Wholesalers That Sell or Market Products in Nevada Must Submit Certification and Compliance Forms to the Nevada Board of Pharmacy by June 1, 2019

April 05, 2019


The Centers for Medicare and Medicaid Services Has Rescheduled Its Q&A Session to Wednesday, April 10, 2019

April 04, 2019


Drug Manufacturers Must Submit Annual Disclosure Reports to the Minnesota Board of Pharmacy by May 1, 2019

April 03, 2019


CMS Has Announced That the Review and Dispute Period for Physicians and Teaching Hospitals is April 1, 2019, Through May 15, 2019

April 01, 2019


The Centers for Medicare and Medicaid Services Will Hold Its Next Q&A Session on Wednesday, March 27, 2019

March 20, 2019


Federal Sunshine Payments Eligible for Delayed Publication Must Have the Delay Indicator Renewed in Each Applicable Program Year

March 13, 2019


Reporting Entities Registered in Open Payments Must Recertify Before Submitting Data for Upcoming Reporting Period

March 12, 2019


Applicable Manufacturers and GPOs Must Submit Their 2018 Sunshine Act Data in CMS' Open Payments System by March 31, 2019

March 07, 2019


Federal Drug Samples Disclosure Reports for Calendar Year 2018 Are Due April 1, 2019; Companies Must Have FDA Electronic Submissions Gateway Account to Submit

February 25, 2019


The U.S. Supreme Court Denies Maryland's Petition Requesting Review of Fourth Circuit Opinion Striking Down Drug Price Gouging Law

February 22, 2019


Prescription Drug, Biological Product, and Medical Device Manufacturers Must Submit Their Disclosure Reports to the Vermont Attorney General's Office by April 1, 2019; 2018 Guide to Disclosure Law is Available

February 21, 2019


Nevada Pharmaceutical Representative Annual Disclosure Reports Due 3/1/2019

February 14, 2019


Philadelphia City Council Votes to Defeat Proposed Ordinance Regulating Pharmaceutical Representative Sales and Marketing Activity

February 08, 2019


CMS Announces That Applicable Manufacturers and GPOs May Begin Data Submission for Payments or Transfers of Value That Occurred in the 2018 Calendar Year

February 04, 2019


Reporting Entities Registered in Open Payments Must Recertify Annually

January 29, 2019


The Minnesota Board of Pharmacy Has Posted the Payments to Practitioners Reporting Form for the 2018 Calendar Year

January 28, 2019


The Centers for Medicare and Medicaid Services Will Hold Open Payments Webinar Session on Wednesday, February 13, 2019

January 25, 2019


The Centers for Medicare and Medicaid Services Has Published an Open Payments Data Refresh

January 22, 2019


The Nevada Department of Health and Human Services Has Posted the 2019 Draft Essential Diabetes Drug List

January 16, 2019


Oregon Has Issued a Notice of Proposed Rulemaking to Implement Drug Price Transparency Law

January 07, 2019


Connecticut Lobbyists Must Renew Their Registrations With the Office of State Ethics by January 15, 2019

January 04, 2019


Reminder: Manufacturers of Prescribed Products Must Submit Their 2018 Compliance Officer Form and Registration Fee to the Vermont Attorney General's Office by January 1, 2019

December 27, 2018


The Centers for Medicare and Medicaid Services Has Posted Updated Quick Reference Guides and Overview for the 2018 Program Year

December 26, 2018


Miami-Dade County, Florida Annual Lobbyist Printable Registration Form is Now Available

December 18, 2018


Nevada Department of Health and Human Services Has Posted Pharmaceutical Sales Representatives Reporting Instructions and Template

December 14, 2018


CMS Announces that the Open Payments System Will Undergo Scheduled System Upgrades; Posts 2018 Data Submission Resources

December 07, 2018


Philadelphia Amends Proposed Ordinance Regulating Pharmaceutical Representative Sales and Marketing Activity After Public Hearing

December 06, 2018


Miami-Dade County, Florida Lobbyists Must Renew Their Annual Lobbyist Registrations by January 15, 2019

December 04, 2018


Pharmaceutical Manufacturers Must Submit Their Annual Nevada Sales Representative List by 1/15/2019

December 03, 2018


Philadelphia Committee on Public Health and Human Services Will Hold a Hearing on Proposed Gift Ban Ordinance

November 29, 2018


Louisiana Lobbyists Must Renew Their Registration Between December 1, 2018 and January 31, 2019

November 27, 2018


The Vermont AG's Office Has Posted the 2018 Compliance Officer Form, Which is Due January 1, 2019

November 20, 2018


The Centers for Medicare and Medicaid Services Will Publish a Refresh of Open Payments Data in January 2019

November 09, 2018


Philadelphia Proposes Amendments to its Code of Ordinances to Require Registration of Pharmaceutical Representatives and to Prohibit Gifts to Practitioners

November 02, 2018


President Trump Signs Legislation That Expands the Sunshine Act's Definition of Covered Recipient

October 25, 2018


The "SUPPORT for Patients and Communities Act" Has Been Delivered to the President

October 18, 2018


The U.S. Senate Has Introduced Legislation Amending the Definition of Covered Recipient for Reporting by Manufacturers of Opioids

October 17, 2018


The U.S. House of Representatives Has Passed the "SUPPORT for Patients and Communities Act"

October 03, 2018


Advanced Medical Technology Association Issues Statement Regarding Proposed Revision to Federal Sunshine Act

September 24, 2018


U.S. Senate Has Passed the "Opioid Crisis Response Act of 2018"

September 21, 2018


The Written Comment Period for New Jersey Proposed Revisions to the Rule Limiting Prescriber Acceptance of Compensation from Pharmaceutical Manufacturers Ends on October 5, 2018

September 14, 2018


The Centers for Medicare and Medicaid Services Has Posted on Its Open Payments Website the 2019 List of Teaching Hospitals and the Adjusted 2019 Reporting Threshold for Payments or Other Transfers of Value

September 11, 2018


Reminder: Pharmaceutical and Medical Device Manufacturers Must Renew Registration With the Massachusetts Department of Public Health by August 31, 2018

August 24, 2018


he Centers for Medicare and Medicaid Services is Soliciting Comments From Stakeholders Regarding Aspects of the Open Payments Program

August 23, 2018


Nevada Department of Health and Human Services Has Posted Revised Pharmaceutical Sales Representatives Registration Instructions

August 14, 2018


OIG Releases "Open Payments Data: Review of Accuracy, Precision, and Consistency in Reporting"

August 13, 2018


The New Jersey Attorney General Has Proposed Revisions to the Rule Limiting Prescriber Acceptance of Compensation from Pharmaceutical Manufacturers

August 07, 2018


Nevada Department of Health and Human Services Has Posted Pharmaceutical Sales Representatives Registry Reporting Instructions and Template

July 30, 2018


Nevada Department of Health and Human Services Has Posted Drug Transparency Reporting Instructions and Templates

July 20, 2018


Pharmaceutical and Medical Device Manufacturers Must Renew Registration With the Massachusetts Department of Public Health by August 31, 2018

July 17, 2018


The Centers for Medicare and Medicaid Services Has Published Program Year 2017 Open Payments Data

July 10, 2018


CMS has Published its Annual Report to Congress on the Open Payments Program

July 03, 2018


The U.S. Senate Has Introduced Legislation to Amend the Definition of Covered Recipient and Expand the Nature of Payment Descriptors

June 26, 2018


Reminder: The Massachusetts Department of Health is Requesting Annual Disclosure Reports be Submitted by July 1 for Compliance and Again Between July 1 and August 31 to be Accepted

June 25, 2018


Registered Lobbyists in Miami-Dade County, Florida Must Submit Their Annual Lobbyist Expenditure Report to the Board of County Commissioners by July 1, 2018

June 18, 2018


Prescription Drug Manufacturers and Labelers That Market in the District of Colombia Must Submit Their Annual Prescription Drug Marketing Costs Report by July 1, 2018

June 13, 2018

Registered Lobbyists in Miami-Dade County, Florida Must Submit Their Annual Lobbyist Expenditure Report to the Board of County Commissioners by July 1, 2018


Nevada Department of Health and Human Services Has Posted its Senate Bill 539 Report: Compensation and Samples Distributed by Pharmaceutical Sales Representatives in Nevada

June 12, 2018


The U.S. Senate Has Introduced Legislation to Amend the Definition of Covered Recipient

June 06, 2018


Applicable Manufacturers Must Submit Their Reports of Payments or Other Transfers of Value to APRNs Engaged in Independent Practice in Connecticut by July 1, 2018

June 01, 2018


Reminder: The Open Payments Data Correction Period Will End on May 30, 2018

May 29, 2018


The Massachusetts Department of Health is Requesting Annual Disclosure Reports be Submitted by July 1st for Compliance and Again Between July 1st and August 31st to be Accepted

May 18, 2018


The New Jersey Assembly Has Introduced Legislation That Would Create the Pharmaceutical Representative Licensing Act, and Provide for the Licensure of Pharmaceutical Representatives

May 17, 2018


The Open Payments Data Correction Period Begins Today, May 16, 2018, and Will End on May 30, 2018

May 16, 2018


Applicable manufacturers have until May 30th to resolve disputes such that changes will be reflected in the June 30th initial publication.

May 11, 2018


U.S. Senate Introduces Legislation to Establish Licensure and Reporting Requirements for Pharmaceutical Representatives Promoting Opioids

May 04, 2018


The District of Columbia Department of Health has Posted on Its Website the 2017 Prescription Drug Marketing Cost Reporting Form

May 03, 2018


Reminder: The Open Payments Review and Dispute Period for Physicians and Teaching Hospitals Will End on May 15, 2018

May 01, 2018


Manufacturers and Wholesalers That Sell or Market Products in Nevada Must Submit Certification and Compliance Forms to the Nevada Board of Pharmacy by June 1, 2018

April 13, 2018


California Requires Pharmaceutical and Medical Device Companies to Annually Declare Compliance with Their Comprehensive Compliance Program

April 10, 2018


Drug Manufacturers Must Submit Annual Disclosure Reports to the Minnesota Board of Pharmacy by May 1, 2018

April 05, 2018


CMS Has Announced That the Review and Dispute Period for Physicians and Teaching Hospitals is Sunday, April 1, 2018, Through Tuesday, May 15, 2018

April 02, 2018


The Centers for Medicare and Medicaid Services Will Hold Its Next Q&A Session on Wednesday, March 28, 2018

March 22, 2018


Vermont Marketing Disclosure Reports are Due on April 2, 2018; Food and Beverage Expenditures Can Be Either Banned, or Permitted and Reportable

March 14, 2018


Federal Drug Sample Disclosure Reports for Calendar Year 2017 are Due Sunday, April 1, 2018

March 13, 2018


Nevada Department of Health and Human Services Has Posted an Updated S.B. 539 Implementation Timeline

March 12, 2018


Applicable Manufacturers and GPOs Must Submit Their 2017 Sunshine Act Data in CMS' Open Payments System by March 31, 2018

March 07, 2018


The Vermont Attorney General's Office Has Posted the 2017 Expenditure and Sample Disclosure Forms for Reporting Under the Prescribed Products Gift Ban and Disclosure Law

March 06, 2018


Nevada Department of Health and Human Services Will Not Issue Sanctions for Late Disclosure Reports Until October

February 22, 2018


The Centers for Medicare and Medicaid Services Has Posted Updated Quick Reference Guides on Its Open Payments Website

February 20, 2018


Pharmaceutical Detailers in the District of Columbia Must Renew Their Licenses by February 28, 2018

February 16, 2018


Reminder – Reporting Entities Registered in Open Payments Must Recertify Annually

February 14, 2018


Colorado Introduces Legislation That Would Require Manufacturers of Select Diabetes Drugs to Report Pricing and Price Increase Information

February 12, 2018


The Centers for Medicare and Medicaid Services Will Hold Its Next Q&A Session on Wednesday, February 7, 2018

February 06, 2018


CMS Announces That Applicable Manufacturers and GPOs May Begin Data Submission for Payments or Transfers of Value That Occurred in the 2017 Calendar Year

February 01, 2018


The Minnesota Board of Pharmacy Has Posted the Payments to Practitioners Reporting Form for the 2017 Calendar Year

January 29, 2018


New Jersey Senate Introduces Legislation That Would Require Certification of Health Care Industry Representatives

January 24, 2018


Washington Introduces Legislation to Require Prescription Drug Manufacturers to Disclose Certain Wholesale Acquisition Cost Increases

January 23, 2018


The Centers for Medicare and Medicaid Services Has Published a Refresh of Open Payments Data

January 22, 2018


Nevada Department of Health and Human Services Issued Revised Guidance Documents for SB 539 Reporting and FAQ – Drug Transparency

January 19, 2018


New Jersey Limitations on Compensation From Pharmaceutical Manufacturers by Prescribers is Effective as of January 16, 2018

January 18, 2018


Nevada Department of Health and Human Services Posted Draft Regulations for its Drug Transparency Law

January 11, 2018


The New Jersey Attorney General Has Adopted Regulations to Prohibit Prescriber Acceptance of Manufacturer Gifts, With Revisions

January 10, 2018


Mississippi Has Introduced Legislation That Would Prohibit Manufacturers and Wholesale Distributors from Price Gouging of Essential Generic Drugs

January 05, 2018


Reporting Entities Registered in Open Payments Must Recertify Annually

January 04, 2018


Simplify Aggregate Spend Compliance with an Internet-based Tracking and Reporting Solution

Request a Demo